CASI Pharmaceuticals Inc (CASI)
2.65
-0.04
(-1.49%)
USD |
NASDAQ |
Dec 20, 16:00
2.65
0.00 (0.00%)
Pre-Market: 20:00
CASI Pharmaceuticals Total Liabilities (Quarterly): 49.77M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.390B |
| China Pharma Holding Inc | 6.937M |
| Zai Lab Ltd | 317.68M |
| Adagene Inc | 44.19M |
| LakeShore Biopharma Co Ltd | 118.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.62M |
| Shareholders Equity (Quarterly) | 13.85M |
| Debt to Equity Ratio | 1.381 |
| Current Ratio | 3.199 |
| Net Debt Paydown Yield | -4.02% |